Mavacamten in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy

Mavacamten in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy

There are no approved therapies for patients with symptomatic nonobstructive hypertrophic cardiomyopathy (nHCM). The authors describe the baseline characteristics of ODYSSEY-HCM (A Study of Mavacamten in Non-Obstructive Hypertrophic Cardiomyopathy), a phase 3, randomized, double-blind, placebo-contr...

Cur síos iomlán

Sábháilte in:
Sonraí bibleagrafaíochta
Príomhchruthaitheoirí: Milind Y. Desai, S.E. Nissen, Theodore P. Abraham, Iacopo Olivotto, Pablo García‐Pavía, Renato D. Lopes, Nicolas Verheyen, Omar Wever‐Pinzon, Kathy Wolski, Wael A. Jaber, Lisa Mitchell, Deborah Davey, Jonathan Myers, Thomas A. Rano, Vandana Bhatia, Yue Zhong, Suzanne Carter-Bonanza, Victoria Florea, Ron Aronson, Anjali Owens
Formáid: Artigo
Teanga:Béarla
Foilsithe / Cruthaithe: 2025
Rochtain ar líne:https://doi.org/10.1016/j.jchf.2024.11.013
Clibeanna: Cuir clib leis
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!

Ar líne

https://doi.org/10.1016/j.jchf.2024.11.013

Míreanna comhchosúla